| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 7 |
| 1 | LETROZOLE | 7 |
| 2 | LETROZOLE TABLETS | 7 |
| 3 | QUETIAPINE | 7 |
| 4 | SIMVASTATIN | 7 |
| 5 | VENLAFAXINE | 7 |
| 6 | VENLAFAXINE HYDROCHLORIDE | 7 |
| 7 | FULVESTRANT | 6 |
| 8 | RISPERIDONE | 6 |
| 9 | OSIMERTINIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRALSETINIB | 2 | 0.0011 |
| 1 | VANDETANIB | 1 | 0.0006 |
| 2 | ERGOCALCIFEROL | 7 | 0.0002 |
| 3 | FULVESTRANT | 6 | 0.0002 |
| 4 | GOSERELIN | 2 | 0.0001 |
| 5 | LETROZOLE TABLETS | 7 | 0.0001 |
| 6 | LETROZOLE | 7 | 0.0001 |
| 7 | OLAPARIB | 2 | 0.0001 |
| 8 | RISPERIDONE | 6 | 0.0001 |
| 9 | PEMETREXED DISODIUM | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 1 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Aromatase Inhibitor [EPC] | 8 | 0.0001 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 7 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 10 | 0.0000 |
| 6 | Atypical Antipsychotic [EPC] | 7 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |